LIVZON PHARMA 01513Hong Kong Stock Exchange

22.1604.43%( +0.940 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
LIVZON PHARMA (01513) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE100001QV5

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)14.10B16/112
Net Profit (Last FY)2.37B13/125
ROE (Last FY)14.57%15/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
刘大平 Executive Director
唐阳刚 Executive Director
林楠棋 Non-Executive Director
邱庆丰 Non-Executive Director
冉永梅 Non-Executive Director
罗会远 Independent Non-Executive Director
崔丽婕 Independent Non-Executive Director
王智瑶 Independent Non-Executive Director
康立 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-09-11.

About this page

This page shows LIVZON PHARMA (01513) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.